undergoes marked structural change throughout normal pregnancy and becomes elongated significantly. It is composed of a mixture of myocytes from body and fibroblasts with extracellular matrix which forms the passive lower uterine segment during labor in vaginal delivery. However, its contribution to uterine contractile dysfunction involving PAM is still unknown. Our aim is to investigate isthmus tissue of PAM cases and find its involvement in the inflammatory changes observed in uterus affected by AFE. STUDY DESIGN: Under the AFE Registry Program in Japan, all AFE cases are registered and investigated in our university in the department of OBGY. We investigated isthmus tissue of these cases and performed immunohistochemistry for inflammatory cell markers-Neutrophil elastase, mast cell tryptase, CD68, CD3 and C5a receptor and observed their expression. Control isthmus tissues were obtained from elective cesarean section patients from the site of lower uterine incision. Winroof software (Mitani Corporation) was used for image analysis and Mann Whitney U test for statistical analysis. RESULTS: A significant number of degranulating mast cells were observed in PAM isthmus as compared to controls (P<0.05) indicating an anaphylactoid reaction in AFE. The number of infiltrating neutrophils in PAM was also significantly more than controls (P<0.001) showing an acute inflammatory reaction in the uterus. CONCLUSION: Marked inflammatory changes were observed both in isthmus and myometrium in the uterus involving AFE which suggests broad development of inflammation, possibly leading to severe uterine atony and postpartum hemorrhage. increasing BMI has additive adverse perinatal effects when added to common comorbidities like hypertension (HTN) and/or diabetes (DM). We sought to evaluate if increasing BMI class is associated with worsening perinatal outcomes in women with HTN and/or DM delivered by pre-labor elective repeat cesarean delivery (ERCD) and to identify the gestational age (GA) at birth between 37-39 weeks at which these morbidities are minimized. STUDY DESIGN: We performed a secondary analysis of a prospective cohort of women undergoing ERCD performed at 19 centers in the MFMU from 1999-2002. Women with HTN and/or DM and nonanomalous singletons delivered by term pre-labor ERCD were included. Women with comorbidities other than HTN or DM or non-elective CD were excluded. Primary outcome was composite neonatal morbidity; secondary outcomes included composite maternal morbidity and individual components of the composites (Table) . Incidences of outcomes were calculated for women with HTN, DM, and HTN and/or DM and stratified by BMI class. Multivariable logistic regression was used to calculate adjusted ORs (with 95% CIs) with BMI <30 as reference. Mantel-Haenszel test was used to evaluate the relationship between BMI class and each comorbidity stratified by week GA at delivery. RESULTS: Of 13350 women who underwent ERCD, 786 with documented BMI and either HTN, DM, or HTN and/or DM were analyzed. There was no significant difference in composite neonatal morbidity (or individual components) by BMI class in women with HTN, DM, or HTN and/or DM (Figure /Table) . However, there was increasing composite maternal morbidity (p¼NS) and a significant increase in incidence of wound complications (p¼0.04) with increasing BMI class in women with HTN and/or DM. There were no significant relationships between BMI class, HTN and/or DM, and any outcome across week GA at delivery (p¼NS). CONCLUSION: While BMI 40 increases neonatal morbidity in healthy women, there appears to be no additive effect of increasing BMI class, regardless of GA at delivery, in women with HTN and/or DM.
844 The effect of IOL before 40 weeks on CD rate in advanced maternal age pregnancies OBJECTIVE: Advanced maternal age pregnancies are commonly induced after 40 weeks. It is debatable whether term induction of labor (IOL) before 40 weeks gestation increases the risk of a cesarean delivery (CD). The purpose of this study was to evaluate the effect of a hospital's liberal IOL approach prior to 40 weeks in term uncomplicated advanced maternal age pregnancies on CD rate. STUDY DESIGN: We conducted a retrospective population-based cohort study using the 2014 Health Care and Utilization ProjectNationwide Inpatient Sample from the United States. We created a cohort of births taking place in hospitals with at least 200 deliveries and a CD of at least 5%. For our analysis, we included all births to women aged 40 years beyond 37 weeks, excluding pregnancies with indications for CD (malpresentation, multiple gestations, genital herpes and abnormal placentation). Hospitals were categorized as having a liberal IOL approach if the IOL rate was 20% or above. We used descriptive statistics to compare patient characteristics between the hospital groups and used logistic regression to estimate the adjusted effect of hospital IOL practice on CD rate in our target population. RESULTS: The study included 11,490 deliveries that took place in 1,221 hospitals. Of them, 618 hospitals (50.6%) were considered to have a liberal IOL practice of 20% and 603 hospitals did not (49.4%). The hospitals with high IOL rates were more likely to have Caucasian patients that belong to a higher income quartile. Hospitals with liberal IOL practices had lower CD rates than hospitals with a low IOL rate (22.2% vs 29.7% respectively, adjusted odds ratio¼0.73; 95% confidence interval 0.65-0.81, p<0.0001). CONCLUSION: Hospitals with a high IOL rate before 40 weeks have a lower CD rate in uncomplicated pregnancies of advanced maternal age. More liberal practices for IOL prior to 40 weeks may reduce cesarean delivery rates in these higher risk pregnancies. OBJECTIVE: Thyroid cancer is one of the most common cancers in women of reproductive age. The purpose of this study was to evaluate the association between thyroid cancer and pregnancy, delivery and neonatal outcomes. STUDY DESIGN: We conducted a retrospective cohort study using the Healthcare Cost and Utilization Project Nationwide Inpatient Sample database (HCUP-NIS) from the United States. The study included women who delivered between 1999 and 2014. We evaluated pregnancy complications, delivery and neonatal outcomes among pregnant women with thyroid cancer (ICD-9 code 193) and compared them to the obstetric population without thyroid cancer. Logistic regression was used to compare maternal and neonatal outcomes between the two groups, while controlling for maternal baseline confounding variables. RESULTS: The study included 14,513,587 pregnant women, of them 581 women had a diagnosis of thyroid cancer (4/100,000). During the observation period there was an upward trend in the prevalence of thyroid cancer among pregnant women, though not statistically significant (p¼0.147). Women with thyroid cancer were more likely to be older in age, Caucasian, belong to a higher income quartile, have private insurance and more likely to be discharged from an urban teaching hospital. They had a higher chance of having pregestational hypertension. Women with thyroid cancer had a greater chance of delivering vaginally than by cesarean section, requiring transfusion of blood products (OR¼2.06, 95% CI 1.10-3.86), developing venous thromboembolism (OR¼2.42, 95% CI 1.00-5.84) and having a longer postpartum stay (OR¼1.48, 95% CI 1.00-2.19). Neonates of mothers with thyroid cancer were not found to be at increased risk for adverse neonatal outcomes. CONCLUSION: Thyroid cancer is not associated with poorer pregnancy outcomes. In fact, pregnancies complicated with thyroid cancer have comparable maternal and neonatal outcomes to those without thyroid cancer.
Pregnancy outcomes after thyroid cancer
846 Neonatal outcomes by planned mode of delivery in morbidly obese women with prior cesarean section Women who were not candidates for a TOLAC were excluded. Neonatal outcomes of women who had a TOLAC were compared to that of women who underwent a planned repeat cesarean delivery. The primary neonatal outcome was a composite of any of the following: intrapartum neonatal death, neonatal intensive care unit admission, 5-minutes Apgar score <7, and umbilical artery pH < 7.1. Odds ratios and 95% confidence intervals were adjusted for maternal age, parity, BMI, labor induction, pre-gestational diabetes, type of anesthesia, gestational age at delivery, birth weight <10 th percentile, newborn sex and academic center. RESULTS: 1) Of 281,480 women who gave birth during the study period, 2,337 (0.8%) met enrollment criteria; 458 (19.6%) had a TOLAC and 1,879 (80.4%) had a planned repeat cesarean delivery (Figure) . 2) Of the women who underwent a TOLAC, 153 (33.4%) had an intrapartum cesarean delivery. 3) The rate of primary neonatal outcome was similar between the TOLAC and the planned repeat cesarean delivery groups (16.8% vs. 14.1%, p¼0.13). 4) When stratifying outcomes by actual (rather than planned) mode of delivery, a successful TOLAC was not associated with lower or higher odds of primary neonatal outcome (adjOR 0.97, 95%-CI 0.62-1.53) while a failed TOLAC was associated with higher odds of primary neonatal outcome (adjOR 1.77, 95%-CI 1.06-2.95) compared with women who underwent planned cesarean delivery. CONCLUSION: In pregnant women with class II-III obesity between 38-42 weeks of gestation, with prior cesarean section, neonatal outcome is not affected by the planned mode of delivery, although the risk of adverse neonatal outcomes is highest among women who have failed TOLAC.
